D-Waves, Quantum

D-Wave's Quantum Rally: Insiders Cash Out as Washington Buys In

25.05.2026 - 10:53:58 | boerse-global.de

D-Wave Quantum's stock rocketed 65% to a $7.1B market cap after a $100M CHIPS Act award, but revenue dropped to $2.9M, executives sold shares, and dilution concerns overshadow the rally.

D-Wave's Quantum Rally: Insiders Cash Out as Washington Buys In - Bild: über boerse-global.de
D-Wave's Quantum Rally: Insiders Cash Out as Washington Buys In - Bild: über boerse-global.de

The numbers coming out of D-Wave Quantum defy conventional logic. Revenue collapsed to $2.9 million in the first quarter, yet the stock has rocketed roughly 65% in a week, pushing the company’s market capitalization past $7.1 billion. The disconnect between euphoria and fundamentals has become so stark that even the company’s own executives are treating the current price as an opportunity to reduce risk.

On May 21, chief legal officer Diane Nguyen sold 40,000 shares at an average price of around $25, a transaction pre-arranged under a trading plan set last August. She retains roughly 500,000 shares. The next day, an unnamed director disclosed plans to sell nearly 329,000 shares. Such insider moves are routine after sharp rallies, but they send a clear signal: management sees the valuation as rich enough to lock in gains.

The catalyst for the surge was a $100 million preliminary funding award under the CHIPS and Science Act, signed as a memorandum of understanding on May 21. Washington is betting big on domestic quantum computing, with the broader program allocating $2 billion across nine companies. IBM takes the largest slice at $1 billion, while Rigetti Computing and Infleqtion each also received $100 million commitments. Commerce Secretary Howard Lutnick has framed quantum as vital for national defense and biopharma research, giving D-Wave a powerful political stamp of approval.

But that government money comes with a catch. Under the terms still being finalized, D-Wave would issue $100 million worth of common stock to the Commerce Department. The prospect of dilution sits awkwardly alongside the stock’s rally. State support strengthens the balance sheet, but new shares carve into future earnings per share. That tension is why the advance, while spectacular, is not entirely clean.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The company’s operating performance does little to clarify the picture. Net loss reached $18 million in the quarter, and on a trailing twelve-month basis the loss was $355.1 million on revenue of just $24.6 million. Yet there are forward-looking signals that have captured the market’s imagination. Bookings surged nearly 2,000% to a record $33.4 million, driven partly by a $10 million quantum-computing-as-a-service contract with a Fortune 100 client. If those bookings convert into recognized revenue, the trajectory could improve. Analysts currently expect full-year sales of $42 million.

On the technology front, D-Wave is pursuing a dual architecture. It is developing a 100,000-qubit annealing system alongside a 10,000-physical-qubit gate-model system designed to yield roughly 100 logical qubits, a threshold widely considered necessary for commercial relevance. The annealing business is more mature, while the gate-model effort aims at applications in quantum chemistry and quantum AI. Facilities in Boca Raton, New Haven and Burnaby are earmarked for the expansion.

The stock’s technical condition suggests the rally is overheated. The relative strength index sits at 70.1, and the price trades 56.7% above its 50-day moving average and 24.3% above the 200-day line. Annualized one-month volatility is 148%. Short interest, while down 11.5% from the prior period, still represents 52 million shares, or 14.5% of the float. That large short base can amplify upward moves if bears are forced to cover, but it also means skepticism remains embedded in the market.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

Analysts are uniformly bullish. All 13 covering the stock rate it a buy, with a median price target of $35.17 and a range from $19.58 to $45. The biggest test of that optimism comes on June 1, when D-Wave holds its first investor day at the New York Stock Exchange. The event is expected to cover the technology roadmap, commercial traction, the recently acquired Quantum Circuits business, and the broader financial strategy. Follow-up appearances at the TD Cowen, Baird and Rosenblatt conferences through early June will give the company more chances to justify its valuation.

For now, D-Wave’s stock is trading on promise. The CHIPS award validates its strategic importance, and the booking surge hints at real demand. But the insider sales and the pending dilution remind investors that this rally, like many in quantum computing, is built more on hope than on hard profits.

Ad

D-Wave Quantum Stock: New Analysis - 25 May

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

en | US26740W1099 | D-WAVES | boerse | 69415369 |